A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
about
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in miceAnimal models for Ebola and Marburg virus infectionsCurrent ebola vaccinesEbola Vaccination: If Not Now, When?Ebolavirus vaccines for humans and apesClinical development of Ebola vaccinesEbola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent UpdatesEbola virus vaccines: an overview of current approachesMouse models for filovirus infectionsDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesA West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical TrialA review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Global research trends of World Health Organization's top eight emerging pathogens.Ebola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusPlasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.Phase 1 study of pandemic H1 DNA vaccine in healthy adultsProspects for control of emerging infectious diseases with plasmid DNA vaccines.A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus SpeciesExpression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Towards broad protection against Ebolaviruses.Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primatesEbola hemorrhagic fever: current outbreak and progress in finding a cure.DNA vaccines for biodefense.DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trialA West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosisTackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicineSafety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trialFunctional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.Immunomodulator-based enhancement of anti smallpox immune responses.Filovirus vaccines.Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.Harnessing case isolation and ring vaccination to control Ebola.Circulating CXCR5⁺CD4⁺ T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines
P2860
Q21092172-A221B8C9-98DF-47D6-9FD7-EC01D8AF412EQ21131118-CB47E82E-FDFF-4496-B167-BE0540A48BAAQ21534720-74639AD7-DD92-437A-B103-962F7A241E93Q22305299-86E305C2-55F8-4C88-9159-056BE7FE86C8Q24631696-17723CCE-9161-4C8A-99BD-701BAF7C706EQ26775792-EAB0E4C7-CF70-4284-9C5F-A3002DCADEEFQ26798860-2F0C661D-4078-4E54-939F-3D37CD163AC1Q26999232-B78E72D5-A297-41CD-AE4E-D0EC08B4B8AEQ27011569-1A700B5A-8F5B-4C71-B609-8C6A28A61B9FQ27304342-E5F0CF3D-5635-4BC0-A959-29EBD84F591DQ27488963-8EE04BAE-6759-4D37-A4DB-CF3ECD6178BEQ29994671-1CC4F4DA-652E-4147-9BA3-C1B2F5C6A635Q30151375-0E96B426-10E9-40F3-912B-2F4B9798B3FDQ30234637-44D0956D-539A-4E5C-ABB7-1D667CE6E7FEQ30235073-9F8DE83F-81EF-4DD1-8E90-2F80D994CFE0Q30369679-01577866-910F-41CF-87C2-AA929A79C8DAQ30373824-2864E6BF-7657-4064-9F98-E7D5B8D15BC5Q30380454-A2C45A03-3F69-416C-84BE-22FFF16502E2Q30398406-6FCC3A15-9ABE-41DB-B641-49951FE19D91Q33587515-C35808BD-80DA-496E-832D-932D9782567DQ33619065-D1612928-8EC7-4CF3-9F19-1EE6F3BB31CDQ33745567-7907E0DF-E765-489B-B279-E689298177E3Q33787778-0C6B728E-A85F-47B2-937A-24BBDCEBB221Q33837161-256036C8-143B-4F80-B6C9-837EECBBC27FQ34407701-4CB29205-C509-4FE2-9B47-53A7FB9A65DDQ34468847-22F7DDE1-EA48-4669-A107-6945EF2AED16Q34491250-BFEA91A9-2931-488B-8210-D483113F56ECQ34614260-90A30DBF-4654-4029-AA9A-618832E22CEEQ34663554-DA07B0D2-CE17-428B-9D6B-E6715D126979Q34833926-CDA2AD13-9DB1-40B7-8A32-350FA57EE800Q34963118-94419570-5C5B-4BD3-AA24-3CB4E82B2320Q34971349-96AAE4CB-6C32-4871-9100-49416AB1A699Q35048254-AF482428-ACA0-462C-AC0C-912AF7DDEE7FQ35055198-6CA18D0C-7513-425D-8C9A-E708DF5E9B7CQ35193052-E15C99EA-5863-4CD6-B126-41D36AD3171BQ35391402-797A2E00-44C6-461B-8E25-B613FBC7A961Q35558539-D548ED0C-6C53-48C5-BF28-BA05866D8393Q35595035-D243C140-D512-4DA3-BA59-AFD88121EA17Q35646387-103E77FF-215C-4746-979E-82794E4E4B3AQ35762614-C9983D1A-10E8-42C6-8972-B311BC59501B
P2860
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@ast
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@en
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@nl
type
label
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@ast
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@en
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@nl
prefLabel
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@ast
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@en
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@nl
P2093
P2860
P921
P356
P1476
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
@en
P2093
Bimal K Chakrabarti
Charla A Andrews
Ingelise J Gordon
Judith A Stein
Julie E Martin
Mario Roederer
Mary E Enama
Michael A Bailey
Nancy J Sullivan
P2860
P304
P356
10.1128/CVI.00162-06
P577
2006-09-20T00:00:00Z